Farmathé: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
Farmathé
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€420,126
2024 · €460,874-€40,748
Equity
€6.6m
2024 · €6.2m+€399,566
Cash
€587,925
2024 · €589,217-€1,293
Balance sheet total
€7.4m
2024 · €6.9m+€484,692
Largest movements
Assets
- Current investments +€550,592
up €550,592 (+12.3%), from €4.5m to €5.0m
- Financial fixed assets -€82,137
down €82,137 (-7.2%), from €1.1m to €1.1m
Equity and liabilities
- Reserves +€395,000
up €395,000 (+6.5%), from €6.1m to €6.5m
of which Distributable reserves: +€395,000
Income statement
- Financial income +€35,599
up €35,599 (+39.8%), from €89,422 to €125,021
- Financial charges +€31,859
up €31,859, from -€5,273 to €26,586
- Gross operating margin -€27,511
down €27,511 (-4.1%), from €677,135 to €649,624
- Taxes +€8,479
up €8,479 (+4.9%), from €172,281 to €180,760
- Staff costs +€7,297
up €7,297 (+6.6%), from €110,572 to €117,869
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€460,874
Gross operating margin
-€27,511
Staff costs
-€7,297
Depreciation
-€945
Other operating charges
-€255
Financial income
+€35,599
Financial charges
-€31,859
Taxes
-€8,479
Result 2025
€420,126
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€513,391
Investment
-€494,123
Financing
-€20,560
Cash 2024
€589,217
From operations (derived)
+€513,391
Net result for the year
+€420,126
Depreciation
+€22,193
Stocks and contracts
+€7,683
Receivables within one year
-€18,946
Deferred charges and accrued income
-€2,791
Trade debts
+€52,074
Tax, wage and social debts
+€2,520
Other debts
+€30,918
Accrued charges and deferred income
-€386
Investment (derived)
-€494,123
Investment in fixed assets (net)
+€56,468
Current investments
-€550,592
Financing
-€20,560
Contributions, distributions and other
-€20,560
Cash 2025
€587,925
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €6,889,174 | €7,373,867 | +€484,692 | +7.0% |
| Fixed assets | 21/28 | €1,322,953 | €1,244,292 | -€78,661 | -5.9% |
| Tangible fixed assets | 22/27 | €175,309 | €178,784 | +€3,476 | +2.0% |
| Land and buildings | 22 | €73,762 | €65,562 | -€8,200 | -11.1% |
| Plant, machinery and equipment | 23 | €18,568 | €33,835 | +€15,268 | +82.2% |
| Furniture and vehicles | 24 | - | €1,395 | +€1,395 | |
| Other tangible fixed assets | 26 | €82,979 | €77,993 | -€4,987 | -6.0% |
| Financial fixed assets | 28 | €1,147,645 | €1,065,508 | -€82,137 | -7.2% |
| Current assets | 29/58 | €5,566,221 | €6,129,574 | +€563,353 | +10.1% |
| Stocks and contracts in progress | 3 | €290,061 | €282,378 | -€7,683 | -2.6% |
| Stocks | 30/36 | €290,061 | €282,378 | -€7,683 | -2.6% |
| Amounts receivable within one year | 40/41 | €219,621 | €238,567 | +€18,946 | +8.6% |
| Trade receivables | 40 | €158,919 | €177,735 | +€18,816 | +11.8% |
| Other amounts receivable | 41 | €60,702 | €60,833 | +€131 | +0.2% |
| Current investments | 50/53 | €4,464,167 | €5,014,758 | +€550,592 | +12.3% |
| Cash at bank and in hand | 54/58 | €589,217 | €587,925 | -€1,293 | -0.2% |
| Deferred charges and accrued income | 490/1 | €3,154 | €5,945 | +€2,791 | +88.5% |
| Total equity and liabilities | 10/49 | €6,889,174 | €7,373,867 | +€484,692 | +7.0% |
| Equity | 10/15 | €6,178,610 | €6,578,176 | +€399,566 | +6.5% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €6,106,086 | €6,501,086 | +€395,000 | +6.5% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Tax-exempt reserves | 132 | €54,226 | €54,226 | = | 0.0% |
| Distributable reserves | 133 | €6,050,000 | €6,445,000 | +€395,000 | +6.5% |
| Profit (loss) carried forward | 14 | €53,924 | €58,491 | +€4,566 | +8.5% |
| Amounts payable | 17/49 | €710,564 | €795,690 | +€85,126 | +12.0% |
| Amounts payable within one year | 42/48 | €684,315 | €769,827 | +€85,512 | +12.5% |
| Trade debts | 44 | €67,776 | €119,850 | +€52,074 | +76.8% |
| Suppliers | 440/4 | €67,776 | €119,850 | +€52,074 | +76.8% |
| Taxes, remuneration and social security | 45 | €55,880 | €58,401 | +€2,520 | +4.5% |
| Taxes | 450/3 | €43,930 | €45,751 | +€1,820 | +4.1% |
| Remuneration and social security | 454/9 | €11,950 | €12,650 | +€700 | +5.9% |
| Other amounts payable | 47/48 | €560,659 | €591,577 | +€30,918 | +5.5% |
| Accrued charges and deferred income | 492/3 | €26,249 | €25,863 | -€386 | -1.5% |
| Remuneration, social security and pensions | 62 | €110,572 | €117,869 | +€7,297 | +6.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €21,248 | €22,193 | +€945 | +4.4% |
| Other operating charges | 640/8 | €6,855 | €7,111 | +€255 | +3.7% |
| Gross operating margin | 9900 | €677,135 | €649,624 | -€27,511 | -4.1% |
| Operating profit (loss) | 9901 | €538,460 | €502,451 | -€36,009 | -6.7% |
| Financial income | 75/76B | €89,422 | €125,021 | +€35,599 | +39.8% |
| Recurring financial income | 75 | €89,422 | €125,021 | +€35,599 | +39.8% |
| Financial charges | 65/66B | -€5,273 | €26,586 | +€31,859 | |
| Recurring financial charges | 65 | -€5,273 | €26,586 | +€31,859 | |
| Profit (loss) for the period before taxes | 9903 | €633,155 | €600,886 | -€32,269 | -5.1% |
| Income taxes | 67/77 | €172,281 | €180,760 | +€8,479 | +4.9% |
| Profit (loss) for the period | 9904 | €460,874 | €420,126 | -€40,748 | -8.8% |
| Profit (loss) for the period to be appropriated | 9905 | €460,874 | €420,126 | -€40,748 | -8.8% |
Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.